XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Premiums $ 10,647 $ 11,230 $ 32,328 $ 32,497
Universal life and investment-type product policy fees 1,228 1,334 3,757 3,911
Net investment income 5,227 4,825 15,868 14,542
Other revenues 648 606 1,960 1,866
Net investment gains (losses) (77) (927) (873) (2,650)
Net derivative gains (losses) 767 (1,202) (720) (2,289)
Total revenues 18,440 15,866 52,320 47,877
Expenses        
Policyholder benefits and claims 10,597 11,130 32,156 32,811
Policyholder liability remeasurement (gains) losses (132) (17) (164) (42)
Market risk benefit remeasurement (gains) losses 531 (796) (345) (1,425)
Interest credited to policyholder account balances 2,037 1,658 6,327 5,455
Policyholder dividends 150 153 445 463
Other expenses 3,263 3,204 9,660 9,394
Total expenses 16,446 15,332 48,079 46,656
Income (loss) before provision for income tax 1,994 534 4,241 1,221
Provision for income tax expense (benefit) 653 39 1,072 233
Net income (loss) 1,341 495 3,169 988
Less: Net income (loss) attributable to noncontrolling interests (1) 6 14 17
Net income (loss) attributable to MetLife, Inc. 1,342 489 3,155 971
Dividends, Preferred Stock 67 67 168 165
Net income (loss) available to MetLife, Inc.’s common shareholders 1,275 422 2,987 806
Comprehensive income (loss) 4,838 (3,373) 5,174 (661)
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax 0 6 17 1
Comprehensive income (loss) attributable to MetLife, Inc. $ 4,838 $ (3,379) $ 5,157 $ (662)
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:        
Basic $ 1.82 $ 0.56 $ 4.20 $ 1.05
Diluted $ 1.81 $ 0.56 $ 4.17 $ 1.05